Go to Client Portal

Paul Risborough, B-Eng (HONS)

Principal Regulatory Consultant

Reserve your Consultation with our Experts

Contact Us

Paul Risborough, who joined NAMSA in June 2021, has over 25 years’ experience in the medical device industry, working with many active medical device technologies. Paul began his medical device career as an Electronics Technician supporting the design and manufacture of syringe pumps. He stayed in the infusion device industry for several years, developing the Alaris range of syringe pumps and large volume pumps as an Electronics Design Engineer, Production Engineer and an Electronics Engineering Manager. Paul then moved to Integra Neuro Sciences as Production Engineering Manager before moving to ML Electronics as Medical Project Leader. Mr. Risborough’s regulatory career began when he joined BSI as an Active Device Product Specialist in 2011, and in 2013, Paul was appointed as part of the BSI Active Implantable Medical Device (AIMD) Team and in 2015, was promoted to the Global Head of Active Implantable Medical Devices.


  • Experience in the design, manufacture and regulation of active and active implantable medical devices
  • Active device experience, including syringe pumps, large volume pumps, RF, ultrasonic, and gas plasma surgical tools, needle-free injectors and SpO2 meters
  • Active implantable device experience, comprised of Left Ventricular Assist Devices (LVADS), neuro-modulation (DBS, DRG, SCS, SNS, PNS, VNS), CRT/ICDs, continuous glucose monitors and brachytherapy products
  • Notified Body (BSI NB 2797) trained and ISO 13485 and technical documentation assessor
  • Development of Medical Device Regulation (MDR) regulatory and clinical Gap Assessments and remediation plans
  • Oversight and development of MDR new product regulatory and clinical strategies
  • In-depth understanding of risk management to ISO 14971 including, FMEA and FTA
  • High knowledge of software lifecycle management to EN 62304


  • Developed the MDR regulatory strategy for Carcinogenic, Mutagenic, and Reproductive Disrupting materials used in a dental washout system
  • Created MDR regulatory strategies for a new respiratory ventilator, a new surgical robot system and a novel AI/DL-based MRI informatics system
  • Developed the MDR clinical strategy for a new cardiac guide extension catheter
  • Oversaw MDR PSUR SOP and PSUR reports for legacy absorbable sutures
  • Created MDR Clinical Evaluation Report (CER) Gap Assessment for a legacy trans venous imaging system and a legacy neurological aneurysm clips
  • Developed a Risk Assessment of cardiac catheter field failures